Longwood Capital Partners »

Cogent Biosciences shares owned by Longwood Capital Partners

Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by Longwood Capital Partners from 13F filings

Historical chart of Longwood Capital Partners investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by Longwood Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by Longwood Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.5M 103k 14.36

More positions owned by Longwood Capital Partners

Ocular Therapeutix (OCUL)
Cidara Therapeutics Com New (CDTX)
Tourmaline Bio (TRML)
Aadi Bioscience (WHWK)
Insmed Com Par $.01 (INSM)
Bright Minds Biosciences Com New (DRUG)
Argen Se - Sponsored Adr (ARGX)
Amylyx Pharmaceuticals (AMLX)
Terns Pharmaceuticals (TERN)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Compass Therapeutics (CMPX)
Praxis Precision Medicines I (PRAX)
Surrozen Com New (SRZN)
Ascendis Pha- Sponsored Adr (ASND)
Krystal Biotech (KRYS)

View all positions for Longwood Capital Partners

Top funds holding Cogent Biosciences

FMR
BlackRock
Deerfield Management Company
Fairmount Funds Management
Kynam Capital Management
Vanguard Group
Commodore Capital
TCG Crossover Management
State Street Corporation
VR Adviser
Rtw Investments
Geode Capital Management
Henderson Group
Paradigm Biocapital Advisors
Octagon Capital Advisors

View all funds holding Cogent Biosciences